Literature DB >> 33911187

Co-released norepinephrine and galanin act on different timescales to promote stress-induced anxiety-like behavior.

Rachel P Tillage1, Stephanie L Foster1, Daniel Lustberg1, L Cameron Liles1, Katharine E McCann1, David Weinshenker2.   

Abstract

Both the noradrenergic and galaninergic systems have been implicated in stress-related neuropsychiatric disorders, and these two neuromodulators are co-released from the stress-responsive locus coeruleus (LC); however, the individual contributions of LC-derived norepinephrine (NE) and galanin to behavioral stress responses are unclear. Here we aimed to disentangle the functional roles of co-released NE and galanin in stress-induced behavior. We used foot shock, optogenetics, and behavioral pharmacology in wild-type (WT) mice and mice lacking either NE (Dbh-/-) or galanin (GalcKO-Dbh) specifically in noradrenergic neurons to isolate the roles of these co-transmitters in regulating anxiety-like behavior in the elevated zero maze (EZM) either immediately or 24 h following stress. Foot shock and optogenetic LC stimulation produced immediate anxiety-like behavior in WT mice, and the effects of foot shock persisted for 24 h. NE-deficient mice were resistant to the anxiogenic effects of acute stress and optogenetic LC stimulation, while mice lacking noradrenergic-derived galanin displayed typical increases in anxiety-like behavior. However, when tested 24 h after foot shock, both Dbh-/- and GalcKO-Dbh mice lacked normal expression of anxiety-like behavior. Pharmacological rescue of NE, but not galanin, in knockout mice during EZM testing was anxiogenic. In contrast, restoring galanin, but not NE, signaling during foot shock normalized stress-induced anxiety-like behavior 24 h later. These results indicate that NE and noradrenergic-derived galanin play complementary, but distinguishable roles in behavioral responses to stress. NE is required for the expression of acute stress-induced anxiety, while noradrenergic-derived galanin mediates the development of more persistent responses following a stressor.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33911187      PMCID: PMC8208976          DOI: 10.1038/s41386-021-01011-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   8.294


  45 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  Immunohistochemical mapping of galanin-like neurons in the rat central nervous system.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Peptides       Date:  1985 May-Jun       Impact factor: 3.750

Review 3.  Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.

Authors:  R-M Karlsson; A Holmes
Journal:  Amino Acids       Date:  2006-05-29       Impact factor: 3.520

4.  Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.

Authors:  Erwan Le Maître; Swapnali Shantaram Barde; Miklos Palkovits; Rochellys Diaz-Heijtz; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

5.  Distribution of galaninergic immunoreactivity in the brain of the mouse.

Authors:  S E Pérez; D Wynick; R A Steiner; E J Mufson
Journal:  J Comp Neurol       Date:  2001-05-28       Impact factor: 3.215

Review 6.  Neurobiology of depression.

Authors:  Eric J Nestler; Michel Barrot; Ralph J DiLeone; Amelia J Eisch; Stephen J Gold; Lisa M Monteggia
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

7.  Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias.

Authors:  Michelle Elisabeth Kruijshaar; Jan Barendregt; Theo Vos; Ron de Graaf; Jan Spijker; Gavin Andrews
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

8.  Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus.

Authors:  V R Holets; T Hökfelt; A Rökaeus; L Terenius; M Goldstein
Journal:  Neuroscience       Date:  1988-03       Impact factor: 3.590

9.  Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS.

Authors:  T Melander; T Hökfelt; A Rökaeus; A C Cuello; W H Oertel; A Verhofstad; M Goldstein
Journal:  J Neurosci       Date:  1986-12       Impact factor: 6.167

Review 10.  Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness.

Authors:  Tomas Hökfelt; Swapnali Barde; Zhi-Qing David Xu; Eugenia Kuteeva; Joelle Rüegg; Erwan Le Maitre; Mårten Risling; Jan Kehr; Robert Ihnatko; Elvar Theodorsson; Miklos Palkovits; William Deakin; Gyorgy Bagdy; Gabriella Juhasz; H Josée Prud'homme; Naguib Mechawar; Rochellys Diaz-Heijtz; Sven Ove Ögren
Journal:  Front Neural Circuits       Date:  2018-12-21       Impact factor: 3.492

View more
  2 in total

Review 1.  The Neurobiological Links between Stress and Traumatic Brain Injury: A Review of Research to Date.

Authors:  Lexin Zheng; Qiuyu Pang; Heng Xu; Hanmu Guo; Rong Liu; Tao Wang
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

2.  Locus Coeruleus Optogenetic Modulation: Lessons Learned from Temporal Patterns.

Authors:  Carolyn W Harley; Qi Yuan
Journal:  Brain Sci       Date:  2021-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.